Ten year audit of secondary prevention in coronary bypass patients.
Irving
R J
RJ
Department of Medical Sciences, Western General Hospital, Edinburgh EH4 2XU.
Oram
S H
SH
Boyd
J
J
Rutledge
P
P
McRae
F
F
Bloomfield
P
P
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001794:Blood Pressure / Q000502:physiology; D002784:Cholesterol / Q000097:blood; D001026:Coronary Artery Bypass; D006801:Humans; D008485:Medical Audit; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control*; D012307:Risk Factors; D019821:Simvastatin / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D010975:Platelet Aggregation Inhibitors; D002784:Cholesterol; D019821:Simvastatin; D001241:Aspirin